_20260529073616622_a5048c_20260724102330512_417f90.webp?ssl=1)
September 28, 2026: Selmore Pharmaceuticals Limited has filed for a listing on the Main Board of the Pakistan Stock Exchange (PSX) through an initial public offering (IPO) comprising 48,611,112 ordinary shares, set at a floor price of Rs42 per share.
The shares, which carry a par value of Rs10 each, will be offered via the book-building method, with KTrade Securities Limited serving as the lead manager for the issue.
In accordance with Clause 3A(2) of the Public Offering Regulations, 2017, the PSX has uploaded the draft prospectus to its website under the heading “Public Comments on Draft Prospectus of Selmore Pharmaceuticals Limited.”
This information was disseminated via a notification to the Exchange.
